193 related articles for article (PubMed ID: 26384289)
1. Lipid-conjugated Smac analogues.
Micewicz ED; Ratikan JA; Waring AJ; Whitelegge JP; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4419-27. PubMed ID: 26384289
[TBL] [Abstract][Full Text] [Related]
2. Novel dimeric Smac analogs as prospective anticancer agents.
Micewicz ED; Luong HT; Jung CL; Waring AJ; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2014 Mar; 24(6):1452-7. PubMed ID: 24582479
[TBL] [Abstract][Full Text] [Related]
3. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity.
Sun H; Liu L; Lu J; Bai L; Li X; Nikolovska-Coleska Z; McEachern D; Yang CY; Qiu S; Yi H; Sun D; Wang S
J Med Chem; 2011 May; 54(9):3306-18. PubMed ID: 21462933
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP).
Sun H; Stuckey JA; Nikolovska-Coleska Z; Qin D; Meagher JL; Qiu S; Lu J; Yang CY; Saito NG; Wang S
J Med Chem; 2008 Nov; 51(22):7169-80. PubMed ID: 18954041
[TBL] [Abstract][Full Text] [Related]
5. Position of lipidation influences anticancer activity of Smac analogs.
Micewicz ED; Nguyen C; Micewicz A; Waring AJ; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2019 Jul; 29(13):1628-1635. PubMed ID: 31047753
[TBL] [Abstract][Full Text] [Related]
6. Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents.
Bianchi A; Ugazzi M; Ferrante L; Lecis D; Scavullo C; Mastrangelo E; Seneci P
Bioorg Med Chem Lett; 2012 Mar; 22(6):2204-8. PubMed ID: 22342627
[TBL] [Abstract][Full Text] [Related]
7. Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.
Seneci P; Bianchi A; Battaglia C; Belvisi L; Bolognesi M; Caprini A; Cossu F; Franco Ed; Matteo Md; Delia D; Drago C; Khaled A; Lecis D; Manzoni L; Marizzoni M; Mastrangelo E; Milani M; Motto I; Moroni E; Potenza D; Rizzo V; Servida F; Turlizzi E; Varrone M; Vasile F; Scolastico C
Bioorg Med Chem; 2009 Aug; 17(16):5834-56. PubMed ID: 19620011
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP.
Sun H; Nikolovska-Coleska Z; Lu J; Meagher JL; Yang CY; Qiu S; Tomita Y; Ueda Y; Jiang S; Krajewski K; Roller PP; Stuckey JA; Wang S
J Am Chem Soc; 2007 Dec; 129(49):15279-94. PubMed ID: 17999504
[TBL] [Abstract][Full Text] [Related]
10. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
12. Smac mimetics as new cancer therapeutics.
Chen DJ; Huerta S
Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors.
Wang J; Li W
J Pharmacol Exp Ther; 2014 May; 349(2):319-29. PubMed ID: 24623800
[TBL] [Abstract][Full Text] [Related]
14. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
[TBL] [Abstract][Full Text] [Related]
15. SPION-Smac mimetic nano-conjugates: putative pro-apoptotic agents in oncology.
Seneci P; Rizzi M; Ballabio L; Lecis D; Conti A; Carrara C; Licandro E
Bioorg Med Chem Lett; 2014 May; 24(10):2374-8. PubMed ID: 24736115
[TBL] [Abstract][Full Text] [Related]
16. Dual action Smac mimetics-zinc chelators as pro-apoptotic antitumoral agents.
Manzoni L; Gornati D; Manzotti M; Cairati S; Bossi A; Arosio D; Lecis D; Seneci P
Bioorg Med Chem Lett; 2016 Oct; 26(19):4613-4619. PubMed ID: 27578248
[TBL] [Abstract][Full Text] [Related]
17. Application of constrained aza-valine analogs for Smac mimicry.
Chingle R; Ratni S; Claing A; Lubell WD
Biopolymers; 2016 May; 106(3):235-44. PubMed ID: 27087660
[TBL] [Abstract][Full Text] [Related]
18. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
Elsawy MA; Martin L; Tikhonova IG; Walker B
Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811
[TBL] [Abstract][Full Text] [Related]
19. Attenuating Smac mimetic compound 3-induced NF-kappaB activation by luteolin leads to synergistic cytotoxicity in cancer cells.
Bai L; Chen W; Wang X; Ju W; Xu S; Lin Y
J Cell Biochem; 2009 Dec; 108(5):1125-31. PubMed ID: 19739098
[TBL] [Abstract][Full Text] [Related]
20. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
